NotesFAQContact Us
Collection
Advanced
Search Tips
Showing all 3 results Save | Export
Peer reviewed Peer reviewed
Direct linkDirect link
Destin Groff; Wen-Jan Tuan; Kraig Holt; James R. Latronica; Curtis Bone – Journal of Attention Disorders, 2025
Introduction: Prescription stimulants are an effective FDA approved treatment for attention deficit hyperactivity disorder (ADHD) however their safety has come under scrutiny. Multiple studies demonstrate safe use in pediatric populations, but prescriptions are increasing to adults and it is not evident which comorbidities might place people at…
Descriptors: Heart Disorders, Stimulants, Attention Deficit Hyperactivity Disorder, Drug Therapy
Peer reviewed Peer reviewed
Direct linkDirect link
Elisabeth F. Callen; Tarin Clay; Jillian Alai; David W. Goodman; Lenard A. Adler; Stephen V. Faraone – Journal of Attention Disorders, 2024
Objective: Several studies have shown that Adult ADHD presents differently in younger and older adults. We sought to assess the difference in care between these two groups using previously identified quality measures (QMs). Methods: Using electronic health record data, we matched a younger group of ADHD patients to an older group. We then assessed…
Descriptors: Attention Deficit Hyperactivity Disorder, Young Adults, Older Adults, Age Differences
Peer reviewed Peer reviewed
Direct linkDirect link
Durell, Todd; Adler, Lenard; Wilens, Timothy; Paczkowski, Martin; Schuh, Kory – Journal of Attention Disorders, 2010
Objective: Atomoxetine is a nonstimulant medication for treating child, adolescent, and adult ADHD. This meta-analysis compared the effects in younger and older adults. Method: A post hoc analysis was conducted using data from two double-blind, placebo-controlled clinical trials. Data from patients aged 18-25 years were compared with data from…
Descriptors: Rating Scales, Older Adults, Patients, Effect Size